NR2F1 overexpression is reported to upregulate SOX9 through RAR-β (27); SOX9 overexpression has been linked to the promotion of migration, metastasis, and resistance to targeted therapy in melanoma (59, 60). Here, NR2F1 is linked to melanoma.